IgA Nephropathy News and Research

RSS
IgA nephropathy (IgAN), also known as Berger’s disease, is the leading cause of primary glomerulonephritis all over the world. It is autoimmune in origin, characterized by the stimulation of genetically determined formation of concentration of IgA1 with galactose-deficient O-glycans in the hinge-region (Hit 1) in the blood. These stimulate anti-glycan antibody production, followed by binding with the aberrantly glycated IgA1.
Understanding gluten's role in autoimmunity and inflammation

Understanding gluten's role in autoimmunity and inflammation

High-impact clinical trial results  to be presented at ASN Kidney Week 2023

High-impact clinical trial results to be presented at ASN Kidney Week 2023

Do prebiotics and probiotics positively impact cardiovascular and renal health?

Do prebiotics and probiotics positively impact cardiovascular and renal health?

Study supports vaccination for COVID-19 in patients with glomerular diseases

Study supports vaccination for COVID-19 in patients with glomerular diseases

IgA nephropathy: The disease that lies outside the kidney

IgA nephropathy: The disease that lies outside the kidney

New facile strategy for proteome analysis using ultracentrifugation fractionation

New facile strategy for proteome analysis using ultracentrifugation fractionation

Study finds low absolute risk of glomerular disease relapse associated with COVID-19 vaccination

Study finds low absolute risk of glomerular disease relapse associated with COVID-19 vaccination

Adults with primary glomerular disease have high cardiovascular risk, study shows

Adults with primary glomerular disease have high cardiovascular risk, study shows

Study shows glomerulonephritis after SARS-CoV-2 mRNA vaccination likely coincidental

Study shows glomerulonephritis after SARS-CoV-2 mRNA vaccination likely coincidental

Multi-country study provides a clear treatment option for IgA nephropathy

Multi-country study provides a clear treatment option for IgA nephropathy

Pioneering kidney disease research at Leicester receives a major boost on World Kidney Day

Pioneering kidney disease research at Leicester receives a major boost on World Kidney Day

Study evaluates the potential benefits of mass dipstick screening to detect hematuria

Study evaluates the potential benefits of mass dipstick screening to detect hematuria

Results of high-impact clinical trials could affect kidney-related medical care

Results of high-impact clinical trials could affect kidney-related medical care

Study reports safety, efficacy of targeted treatment for IgA nephropathy

Study reports safety, efficacy of targeted treatment for IgA nephropathy

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Low socioeconomic status associated with certain kidney diseases

Low socioeconomic status associated with certain kidney diseases

UAB researchers find key role for IgG autoantibodies in IgA nephropathy

UAB researchers find key role for IgG autoantibodies in IgA nephropathy

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Worldwide study to examine new treatments for IgA nephropathy

Worldwide study to examine new treatments for IgA nephropathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.